Checkmate Pharmaceuticals, Inc. Operating Income 2020-2022 | CMPI
Checkmate Pharmaceuticals, Inc. operating income from 2020 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Checkmate Pharmaceuticals, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2021 | $-61 |
| 2020 | $-37 |
| 2019 | $-29 |
| 2018 | $-21 |
| Checkmate Pharmaceuticals, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2022-03-31 | $-16 |
| 2021-12-31 | $-13 |
| 2021-09-30 | $-15 |
| 2021-06-30 | $-19 |
| 2021-03-31 | $-14 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-8 |
| 2019-12-31 | $-8 |
| 2019-09-30 | $-6 |
| 2019-06-30 | $-7 |
| 2019-03-31 | $-7 |
